---
title: Blog - Launch and Market Access trends in pharma | TRiBECA Knowledge | London | charity donation
description: charity donation | Keep up to date with the latest launch, market access and tender management trends in the pharmaceutical and biotech sector.
---

## Featured Post

### [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges)

- ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-author.png) Andre Moa
- ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-date.png) 21 Jan 2025
- ![](https://www.tribecaknowledge.com/hubfs/website-2022/blog-length.png) 21 minute read

Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.

[Read more](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges)

## Latest posts

### Recent Posts

- [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends)
- [Driving launch excellence with agile transformation](https://www.tribecaknowledge.com/blog/driving-launch-excellence-with-agile-transformation)
- [Launch Readiness 2025: What this year holds in store for pharma product launches](https://www.tribecaknowledge.com/blog/launch-readiness-2025-what-this-year-holds-in-store-for-pharma-product-launches)
- [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges)
- [2024 New Drug Approvals: Key FDA and EMA approvals, breakthroughs and market trends](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends)

### Most Popular Posts

- [2025 New Drug Approvals: Key FDA and EMA approvals and Emerging Trends](https://www.tribecaknowledge.com/blog/2025-new-drug-approvals-key-fda-and-ema-approvals-and-emerging-trends)
- [What Pfizer’s digital transformation strategy can teach us about making pharma more agile and effective](https://www.tribecaknowledge.com/blog/what-pfizers-digital-transformation-strategy-can-teach-us-about-making-pharma-more-agile-and-effective)
- [2024 New Drug Approvals: Key FDA and EMA approvals, breakthroughs and market trends](https://www.tribecaknowledge.com/blog/2024-new-drug-approvals-key-fda-and-ema-approvals-breakthroughs-and-market-trends)
- [6 Pharma Trends for 2025: Trump’s Return, AI Breakthroughs, and Market Access Challenges](https://www.tribecaknowledge.com/blog/6-pharma-trends-for-2025-trumps-return-ai-breakthroughs-and-market-access-challenges)
- [Market Access 2025: Navigating the emerging HTA and drug reimbursement challenges](https://www.tribecaknowledge.com/blog/market-access-2025-new-report-on-navigating-the-emerging-hta-and-drug-reimbursement-challenges)

### Categories

- [launch readiness](https://www.tribecaknowledge.com/blog/topic/launch-readiness)
- [Market access](https://www.tribecaknowledge.com/blog/topic/market-access)
- [Pharma trends](https://www.tribecaknowledge.com/blog/topic/pharma-trends)
- [Pharma launch planning](https://www.tribecaknowledge.com/blog/topic/pharma-launch-planning)
- [launch plan](https://www.tribecaknowledge.com/blog/topic/launch-plan)
- [launch readiness framework](https://www.tribecaknowledge.com/blog/topic/launch-readiness-framework)
- [launch effectiveness](https://www.tribecaknowledge.com/blog/topic/launch-effectiveness)
- [launch strategy](https://www.tribecaknowledge.com/blog/topic/launch-strategy)
- [Tender Management](https://www.tribecaknowledge.com/blog/topic/tender-management)

#### Get our latest posts in your inbox

TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.